相似文献
1
Arsenic trioxide and the phosphoinositide 3-kinase/akt pathway in chronic lymphocytic leukemia.
Clin Cancer Res. 2010 Sep 1;16(17):4311-2. doi: 10.1158/1078-0432.CCR-10-1496. Epub 2010 Jul 9.
2
Induction of B-chronic lymphocytic leukemia cell apoptosis by arsenic trioxide involves suppression of the phosphoinositide 3-kinase/Akt survival pathway via c-jun-NH2 terminal kinase activation and PTEN upregulation.
Clin Cancer Res. 2010 Sep 1;16(17):4382-91. doi: 10.1158/1078-0432.CCR-10-0072. Epub 2010 Jun 9.
3
Bone marrow stroma-induced resistance of chronic lymphocytic leukemia cells to arsenic trioxide involves Mcl-1 upregulation and is overcome by inhibiting the PI3Kδ or PKCβ signaling pathways.
Oncotarget. 2015 Dec 29;6(42):44832-48. doi: 10.18632/oncotarget.6265.
4
Arsenic trioxide induces autophagy and apoptosis in human glioma cells in vitro and in vivo through downregulation of survivin.
J Mol Med (Berl). 2011 Sep;89(9):927-41. doi: 10.1007/s00109-011-0763-1. Epub 2011 May 19.
5
Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells.
J Cell Physiol. 2005 Feb;202(2):623-34. doi: 10.1002/jcp.20153.
6
TG-interacting factor transcriptionally induced by AKT/FOXO3A is a negative regulator that antagonizes arsenic trioxide-induced cancer cell apoptosis.
Toxicol Appl Pharmacol. 2015 May 15;285(1):41-50. doi: 10.1016/j.taap.2015.03.007. Epub 2015 Mar 16.
7
E3 ubiquitin ligase Cbl-b potentiates the apoptotic action of arsenic trioxide by inhibiting the PI3K/Akt pathway.
Braz J Med Biol Res. 2011 Feb;44(2):105-11. doi: 10.1590/s0100-879x2010007500142. Epub 2010 Dec 17.
8
Arsenic trioxide induces apoptosis in B-cell chronic lymphocytic leukemic cells through down-regulation of survivin via the p53-dependent signaling pathway.
Leuk Res. 2013 Dec;37(12):1719-25. doi: 10.1016/j.leukres.2013.09.019. Epub 2013 Sep 29.
9
Gene expression profile induced by arsenic trioxide in chronic lymphocytic leukemia cells reveals a central role for heme oxygenase-1 in apoptosis and regulation of matrix metalloproteinase-9.
Oncotarget. 2016 Dec 13;7(50):83359-83377. doi: 10.18632/oncotarget.13091.
10
Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.
Leuk Lymphoma. 2012 Jul;53(7):1383-9. doi: 10.3109/10428194.2011.650695. Epub 2012 Jan 31.
引用本文的文献
1
Exploring the Mechanisms of Arsenic Trioxide () in Hepatocellular Carcinoma Based on Network Pharmacology.
Evid Based Complement Alternat Med. 2021 Nov 29;2021:5773802. doi: 10.1155/2021/5773802. eCollection 2021.
2
Arsenic Trioxide and Thalidomide Combination Induces Autophagy Along with Apoptosis in Acute Myeloid Cell Lines.
Cell J. 2020 Jul;22(2):193-202. doi: 10.22074/cellj.2020.6469. Epub 2019 Oct 14.
3
Arsenic trioxide-mediated suppression of miR-182-5p is associated with potent anti-oxidant effects through up-regulation of .
Oncotarget. 2018 Mar 23;9(22):16028-16042. doi: 10.18632/oncotarget.24678.
4
Inhibition of angiogenesis by arsenic trioxide TSP-1-TGF-β1-CTGF-VEGF functional module in rheumatoid arthritis.
Oncotarget. 2017 Aug 3;8(43):73529-73546. doi: 10.18632/oncotarget.19867. eCollection 2017 Sep 26.
5
Differential Response of Glioma Stem Cells to Arsenic Trioxide Therapy Is Regulated by MNK1 and mRNA Translation.
Mol Cancer Res. 2018 Jan;16(1):32-46. doi: 10.1158/1541-7786.MCR-17-0397. Epub 2017 Oct 17.
6
Arsenic inhibits mast cell degranulation via suppression of early tyrosine phosphorylation events.
J Appl Toxicol. 2016 Nov;36(11):1446-59. doi: 10.1002/jat.3300. Epub 2016 Mar 28.
7
Arsenic trioxide inhibits growth of human chondrosarcoma cells through G2/M arrest and apoptosis as well as autophagy.
Tumour Biol. 2015 May;36(5):3969-77. doi: 10.1007/s13277-015-3040-z. Epub 2015 Jan 11.
8
Arsenic trioxide induces apoptosis in B-cell chronic lymphocytic leukemic cells through down-regulation of survivin via the p53-dependent signaling pathway.
Leuk Res. 2013 Dec;37(12):1719-25. doi: 10.1016/j.leukres.2013.09.019. Epub 2013 Sep 29.
9
Downregulation of Mcl-1 through GSK-3β activation contributes to arsenic trioxide-induced apoptosis in acute myeloid leukemia cells.
Leukemia. 2013 Feb;27(2):315-24. doi: 10.1038/leu.2012.180. Epub 2012 Jul 3.
10
Arsenic trioxide induces autophagy and apoptosis in human glioma cells in vitro and in vivo through downregulation of survivin.
J Mol Med (Berl). 2011 Sep;89(9):927-41. doi: 10.1007/s00109-011-0763-1. Epub 2011 May 19.
本文引用的文献
1
Induction of B-chronic lymphocytic leukemia cell apoptosis by arsenic trioxide involves suppression of the phosphoinositide 3-kinase/Akt survival pathway via c-jun-NH2 terminal kinase activation and PTEN upregulation.
Clin Cancer Res. 2010 Sep 1;16(17):4382-91. doi: 10.1158/1078-0432.CCR-10-0072. Epub 2010 Jun 9.
2
Arsenic trioxide - An old drug rediscovered.
Blood Rev. 2010 Jul-Sep;24(4-5):191-9. doi: 10.1016/j.blre.2010.04.001. Epub 2010 May 15.
3
The treatment of recurrent/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL) with everolimus results in clinical responses and mobilization of CLL cells into the circulation.
Cancer. 2010 May 1;116(9):2201-7. doi: 10.1002/cncr.25005.
4
The PI3K pathway as drug target in human cancer.
J Clin Oncol. 2010 Feb 20;28(6):1075-83. doi: 10.1200/JCO.2009.25.3641. Epub 2010 Jan 19.
5
Biological responses to arsenic compounds.
J Biol Chem. 2009 Jul 10;284(28):18583-7. doi: 10.1074/jbc.R900003200. Epub 2009 Apr 10.
6
A pilot trial of the mTOR (mammalian target of rapamycin) inhibitor RAD001 in patients with advanced B-CLL.
Ann Hematol. 2009 Mar;88(3):221-7. doi: 10.1007/s00277-008-0582-9. Epub 2008 Aug 14.
7
Regulatory effects of mammalian target of rapamycin-mediated signals in the generation of arsenic trioxide responses.
J Biol Chem. 2008 Jan 25;283(4):1992-2001. doi: 10.1074/jbc.M705227200. Epub 2007 Nov 29.
8
Activation of mammalian target of rapamycin and the p70 S6 kinase by arsenic trioxide in BCR-ABL-expressing cells.
Mol Cancer Ther. 2006 Nov;5(11):2815-23. doi: 10.1158/1535-7163.MCT-06-0263.
9
Role of the p38 mitogen-activated protein kinase pathway in the generation of arsenic trioxide-dependent cellular responses.
Cancer Res. 2006 Jul 1;66(13):6763-71. doi: 10.1158/0008-5472.CAN-05-3699.
10
MEK1 inhibition sensitizes primary acute myelogenous leukemia to arsenic trioxide-induced apoptosis.
Blood. 2006 Jun 1;107(11):4549-53. doi: 10.1182/blood-2005-07-2829. Epub 2006 Feb 7.
Zotero 插件